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Abstract 
We examined the change in the adenylyl cyclase activity of $49 cells occurring after exposure to calcium ionophore, A23187. 
MnCl2-stimulated adenylyl cyclase activity in membrane preparations increased by 67 + 3% (after 24 h treatment with 0.3 p.M A23187), 
while no significant change was found in the basal activity or NaF-, isoproterenol- or forskolin-stimulated activities. An activity sensitive 
to CaClz/calmodulin, which could not be detected in membranes from untreated cells, was found in membranes from A23187-treated 
cells. These changes took place after treatment with 0.1-0.3 ~M A23187 for a period longer than 16 h. A brief treatment of $49 cells 
with phorbol 12-myristate 13-acetate (PMA) enhances the activity of adenylyl cyclase (Bell, J.D. et al. (1985) J. Biol. Chem. 260, 
2625-2628), but exposure of cells to PMA at the end of A23187-treatment didnot affect he induction of the MnC12-or CaCI 2/calmodu- 
lin-sensitive activity. The results indicate that long-term treatment of $49 cells with calcium ionophore, A23187, induces adenylyl cyclase 
activity of a novel type, which is probably caused by an abnormal increase in free intracellular calcium. 
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1. Introduction 
Calcium serves as an intracellular signal in a large 
number of physiological processes, some of which are 
critical for the development, survival and normal function- 
ing of cells [I], Calcium performs ome of these functions 
in a concerted manner with adenylyl cyclase [2-4]. A 
notable example for this is the isoforms of adenylyl cy- 
clase, types I, III and VIII, which respond to calcium and 
can be activated synergistically by calcium/calmodulin 
and Gs [5-8]. 
It is well known that these physiological responses are 
caused by the change in the cytosolic calcium concentra- 
tion, which primarily exerts the effects through regulation 
of gene expression or modulation of the activities of some 
enzymes. In view of the close relationship in functions 
between calcium and adenylyl cyclase as described above, 
it is interesting to know if calcium modifies the activity of 
adenylyl cyclase other than the calcium/calmodulin-sensi- 
tive isoforms. The present work was undertaken to exam- 
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ine the effect of calcium ionophore, A23187, on the adeny- 
lyl cyclase activity of wild-type $49 murine lymphoma 
cells. The adenylyl cyclase system of these cells has been 
characterized biochemically [9] and by the reverse tran- 
scriptase-polymerase chain reaction method [10,11]. The 
cells have two isoforms of adenylyl cyclase, types VI and 
VII [10,11]. Calcium does not enhance the activity of these 
isoforms [5] but decreases the activity of type VI isoform 
[12,13]. We have found that treatment of the cells with 
A23187 for a period longer than 16 h results in an increase 
in MnCl,-stimulated adenyly cyclase activity and a signifi- 
cant induction of calcium/calmodulin-sensitive ad nylyl 
cyclase activity. 
2. Materials and methods 
2.1. Cell culture and treatment of cells 
$49 cells were grown in Dulbecco's modified Eagle's 
medium containing 10% heat-inactivated horse serum [14]. 
A fixed amount of A23187 (15 &l, 0 to 1 mM in dimethyl 
sulfoxide) was added to the cell suspension (50 ml, 4 -6  X 
105 cells/ml) to give final concentrations of 0-0.3 txM. 
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The mixtures were incubated for 24 h at 37°C. After 
incubation, the cells were sedimented by centrifugation for 
5 min at 900 × g (max). After being washed with phos- 
phate-buffered saline, the cells were subjected to the 
preparation of membranes. Cell viability was not affected 
by the presence of A23187 of less than 0.3 txM, when 
assessed by trypan blue exclusion after 24 h treatment. 
2.2. Preparation of membrane fractions 
measured in the presence of 10 mM MnCI 2 in place of 10 
mM MgC12 [15]. 
2.4. Miscellaneous methods 
The amount of cAMP was determined by radioim- 
munoassay [14,16]. Protein concentration was measured by 
Lowry's method [17]. Data were subjected to a Student's 
t-test for examination of statistical significance. 
$49 cells were suspended in a solution containing 25 
mM N-2-hydroxyethylpiperadin-N'-2-ethanesulfonic acid 
(Hepes; pH 7.8)/1 mM EDTA/0.1 mM dithiothreitol and 
were disrupted in a Dounce homogenizer (50 strokes). 
Membrane fractions were obtained as described previously 
[14]. 
2.3. Assay of adenylyl cyclase activity 
The basal adenylyi cyclase activity was determined in
duplicate at 30°C for 20 rain in 100 I~1 of a solution 
containing 50 mM Hepes (pH 7.8), 0.2 mM ATP, i 0 mM 
MgC12, 5 mM phosphoenolpyruvate, 18 Ixg/ml of pyru- 
vate kinase, 0.1 mg/ml of' BSA, 1 mM EDTA and 0.1 
mM RO20-1724 (phosphodiesterase inhibitor). Adenylyl 
cyclase activity was also measured in the presence of 10 
mM NaF/20 I~M AICI 3 (NaF-stimulated activity), 100 
I~M isoproterenol/100 IxM[ GTP (Iso-stimulated activity) 
or 20 t~M forskolin (forskolin-stimulated activity). The 
calcium/calmodulin-sensitive activity was determined in 
the assay mixture containing iven concentrations of CaCI 2 
and calmodulin (bovine brain). Mn-stimulated activity was 
3. Results 
3.1. Effect ofA23187 on adenylyl cyclase actiL, ity in $49 
cells 
$49 cells were treated with varying concentrations of
A23187 for 24 h. Mn-stimulated adenylyl cyclase activity 
in membrane preparations showed a dose-dependent i -
crease, which appeared at the concentrations of A23187 of 
more than 0.1 ixM (Fig. 1, left). No significant increase 
was found in the basal adenylyl cyclase activity of the 
same membrane preparations (results not shown). The 
activities of NaF-, Iso- and forskolin-stimulated a enylyi 
cyclase in membranes from A23187-treated cells did not 
differ from those found in membranes obtained from con- 
trol cells (without A23187) (Fig. 1, right). 
Mn-stimulated adenylyl cyclase activity in membranes 
from control cells did not change over the time examined 
(1-24 h, Table 1). The activity in membranes obtained 
from the cells treated with 0.3 IxM A23187 for 1 or 4 h did 
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Fig. 1. Effects of A23187 on activity of adenylyl cyclase in $49 cells. $49 cells were treated with 0-0.3 I~M A23187 for 24 h, and were then subjected to 
preparation of membranes. Mn-stimulated adenylyl cyclase activity (left, O O), and NaF- (O O) ,  Iso- ([3 ~ rq) and 
forskolin- ( zx - -  za ) stimulated adenylyl cyclase activities (right) in the membrane preparations were determined. Each point represents he mean 
and S.E. for seven determinations. * P < 0.05, * * P < 0.001 in comparison with the value for control-treated (without A23187) cells. 
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Fig. 2. Dose-dependent changes in adenylyl cyclase activity by divalent caions. Adenylyl cyclase activity in membranes from control-treated (without 
A23187 for 24 h, O O)  and A23187-treated (0.3 p.M A23187 for 24 h, • - - -• )  $49 cells were determined in the presence of 0 -30  mM 
MgC12 (left) or 0 -30  mM MnCI 2 (right). In the right, differences in the activities between the two membrane preparations were shown (zx - - -  zx ). 
Each point represents the mean and S.E. for five determinations. * P < 0.05, * * P < 0.02, * * * P < 0.01, * * * * P < 0.001 when compared the values 
for A23187-treated cells to those for control-treated cells. 
by 38% or 67% after treatment for 16 and 24 h, respec- 
tively (P  < 0.02). 
3.2. Change in the adenylyl cyclase activity by divalent 
cation 
Fig. 2 shows the effect of varying concentrations of 
MgCI 2 or MnCI 2 on the adenylyl cyclase activity in 
membranes prepared from $49 cells which were treated for 
24 h with or without 0.3 IxM A23187. In the absence of 
the cations, no measurable cAMP was formed. The rate of 
cAMP formation increased gradually with an increase in 
the concentrations of added MgCI 2 (Fig. 2, left). The 
enzyme activity found in membranes from A23187-treated 
cells was slightly higher (8-19%) than that from control 
cells in the presence of 15 mM or more MgCI z. As for 
MnC12, a maximum activity was found at 5 mM and the 
activity decreased at higher cation concentrations (Fig. 2, 
right). The activity found in membranes prepared from 
A23187-treated cells was higher than the activity for the 
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Fig. 3. Calcium/calmodulin-dependent activity of adenylyl cyclase. Effect of the CaCI 2 concentration on the adenylyl cyclase activity was determined in 
the presence of 0.2 IxM calmodulin (left). Effect of the calmodulin concentration on the adenylyl cyclase activity was determined in the presence of 0.1 
mM CaCI 2 (right). (O  O), membranes from control-treated (without A23187 for 24 h) cells; ( [ ] - - -  [] ), membranes from A23187-treated 
(0.3 Ixm A23187 for 24 h) cells; ( zx - - -  zx ), differences in the activities between the two membrane preparations. Each point represents the mean and 
S.E. for five determinations. * P < 0.05, * * P < 0.01, * * * P < 0.001 in comparison with the value obtained without CaCI 2 (left) or without calmodulin 
(right). + P < 0.05, ++ P < 0.02, +++ P < 0.01, ++++ P < 0.001 when compared the values for A23187-treated cells to those for control-treated cells. 
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Table 1 
Time-dependent changes of Mn-stimulated a enylyl cyclase activity in 
$49 cells exposed toA23187 
Incubation 
time (h) 
Mn-stimulated a enylyl cyclase activity 
(cAMP formed pmol/min/mg protein) 
Control A23187 
1 2.5~0.1 2.5±0.1 
4 2.4±0.2 2.4±0.1 
16 2.4±0.1 3.3±0,1"* 
24 2.4±0.2 4.0±0.3* 
$49 cells were incubated for the time indicated inthe absence (control) or 
presence of0.3 I~M A23187. After incubation, the cells were subjected to
preparation f membranes, and Mn-stimulated a enylyl cyclase activity 
was determined. Data represent mean ± S.E. for four determinations. 
* P < 0.02, * * P < 0.01, when compared tocontrol at each time point. 
control cells. The difference in the activities between the 
two kinds of membrane ]preparations increased as the 
concentration of MnCI z increased, reaching a maximum at 
20 mM (a 55% increase, P < 0.01). 
3.3. Effect o f  calcium / calmodulin on adenylyl cyclase 
activity 
Effect of CaCI z (in the presence of 0.2 IxM of calmod- 
ulin) on the adenylyl cyclase activity was examined (Fig. 
3, left). In membranes from control cells, the activity was 
not affected by the change in the CaC12 concentrations less 
than 0.1 mM but decrease,] remarkably at 1 mM (a 24% 
decrease, P<0.0[ ) .  The activity in membranes from 
A23187-treated (0.3 IxM, 24 h) cells increased as the 
concentration of CaC12 increased, reaching a [5% increase 
(P  < 0.05) at 0.01 mM and a 19% increase (P  < 0.01) at 
0.1 mM, but decreased at 1 mM CaC12 (a 13% decrease, 
P < 0.05). The activity in membranes from A23187-treated 
cells was always higher than the control values, and the 
activation was maximized at 0.1 mM CaC12, showing a 
29% increase (P  < 0.02). 
The effect of calmodulin was determined in the pres- 
ence of 0.1 mM CaC12 (Fig. 3, right). The activity in 
membranes from control cells did not change over the 
calmodulin concentrations examined. On the other hand, 
the activity in membranes, from A23187-treated cells in- 
creased with an increase i.n the calmodulin concentration 
up to 0.2 p~M (a 20% increase, P < 0.01). The difference 
in the activities between the two membrane preparations 
increased with the increase in the concentrations of 
calmodulin and reached a plateau at 0.2 IxM (a 34% 
increase, P < 0.01). 
4. Discussion 
The adenylyl cyclase activity induced by calcium 
ionophore, A23187, is clearly discriminated from the type 
VI isoform of the enzyme in $49 cells, because it does not 
respond to Gs stimulation. The type VII isoform is mani- 
fested in $49 cells after the PMA treatment [11,18]. In the 
present study the PMA treatment (with 0.1 ~M for 10 
min) was found to increase the basal adenylyl cyclase 
activity by 27% (P<0.05) ,  but it did not affect the 
induction of A23187-dependent activity (results not 
shown), indicating that the activity is independent of the 
type VII isoform. 
The stimulatory effect of calcium/calmodulin on the 
A23187-induced adenylyl cyclase activity is particularly 
significant, since the activity is not affected by any other 
regulatory ligand. It is clearly distinctive from the activity 
of calcium/calmodulin-sensitive isoforms found in mam- 
malian cells (except for sperm). The mammalian isoforms 
respond to Gs stimulation by NaF or hormones in the 
presence of calcium/calmodulin [5-8]. The A23187-in- 
duced activity seems to be similar to mammalian sperm 
adenylyl cyclase, as judged from the following character- 
istics. That is, it is insensitive to hormonal stimulation but 
is highly dependent on Mn 2+, as compared with Mg 2÷. 
Furthermore, it lacks the sensitivity to forskolin and is 
activated by calcium/calmodulin [19-21]. The sperm 
adenylyl cyclase has been shown to be associated with 
membranes [19,20], though the enzyme is mostly soluble 
in the cells at the early stages of differentiation. 
The present results, together with other results noted 
above, indicate that calcium ionophore, A23187, induces a 
novel adenylyl cyclase activity in $49 cells. It is known 
that the activity of pre-existing enzyme in $49 cells is 
quite heat labile [9,22], and we examined heat lability of 
the adenylyl cyclase activity in membranes by treating 
them at 30°C for 2 h. There was no difference, however, in 
the heat lability of Mn-stimulated (as well as the basal and 
NaF-stimulated) adenylyl cyclase activities between mem- 
branes from control- and A23187-treated cells (results not 
shown). As far as the heat lability is concerned, the 
A23187-induced activity seems to be similar to the pre-ex- 
isting enzyme. 
It has been shown that Mn 2÷ uncouples the GTP 
binding protein and the catalytic unit protein and activates 
directly the latter component [23,24]. Thus, it seems likely 
that the observed increase in Mn-stimulated adenylyl cy- 
clase activity in A23187-treated $49 cells is caused by the 
change in the activity of catalytic unit, but not by any 
functional alteration of Gs (stimulatory GTP-binding regu- 
latory protein) or Gi (inhibitory GTP-binding regulatory 
protein). It is not known whether induction of the novel 
adenylyl cyclase activity is due to synthesis of an isoform(s) 
that is not present in the untreated $49 cells or due to a 
functional modification of the pre-existing enzyme. An 
attempt o examine the effect of inhibition of protein 
synthesis by cycloheximide on induction of the novel 
activity was unsuccessful, because an extensive cell death 
occurred in the presence of both cycloheximide and A23187 
in the culture medium (results not shown). 
There are observations that the activity of adenylyl 
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cyclase is increased in a variety of cells exposed to ago- 
nists for receptors negatively coupled to adenylyl cyclase, 
such as muscarinic holinergic agonist [25], et 2-adrenergic 
agonist [26], somatostatin [27] and opiate [28]. It has been 
hypothesized that cells exposed to the inhibitory agonist 
undergo adaptation to this agonist actions to maintain 
cellular homeostasis [26,27]. The molecular mechanism of 
the activity increase is not yet defined, though some 
possibilities have been suggested [25-27]. A similar adap- 
tive mechanism ay be possible for the A23187-induced 
adenylyl cyclase activity in $49 cells. A23187 elevates the 
level of free intracellular calcium in cultured cells [29,30], 
though the effect is attenuated after prolonged treatment. 
Increase in free intracellular calcium has been shown to 
inhibit the activity of the type VI isoform [12,13]. Thus, it 
seems possible that A23187 leads to a decreased level of 
cAMP through inhibition of the type VI isoform in $49 
cells and thereby triggers the induction of the novel en- 
zyme activity. To confirm this, studies are required exam- 
ining the relationship between the level of free calcium 
and the induction of the enzyme activity by using calcium 
ionophores or other agents that alter the calcium uptake. In 
our preliminary study, a calcium channel agonist, BAY K 
8644 was ineffective in the induction of the activity (result 
not shown). 
Finally, the present study has shown that $49 cells alter 
the mode of cAMP formation by inducing novel activities 
of adenylyl cyclase during the course of treatment with 
calcium ionophore, A23187. Further characterization f
the novel activities hould lead to a better understanding of 
the role of the adenylyl cyclase system in the calcium 
metabolism. 
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